Concepedia

Robert Elsby

RE

Statistics

Publications

22

Citations

1.5K

H-Index

18

Active since

2000

Affiliations

AstraZeneca (United Kingdom)(Current)

University of Liverpool

Loughborough University

AstraZeneca (United States)

Evotec (United Kingdom)

Robert Elsby is an author at AstraZeneca (United Kingdom) specializing in pharmacology, drug disposition, and pharmacokinetics.

Publications per year

2000–2023

22

Publications

22

Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice

Christopher E. Goldring, Neil R. Kitteringham, Robert Elsby et al. · Hepatology · 2004 · 203 citations · Full text

, , +17

Increased Constitutive c-Jun N-terminal Kinase Signaling in Mice Lacking Glutathione S-Transferase Pi

Robert Elsby, Neil R. Kitteringham, Christopher E. Goldring et al. · Journal of Biological Chemistry · 2003 · 159 citations · Full text

, , +13

Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?

Bruce K. Birmingham, Sarah R. Bujac, Robert Elsby et al. · European Journal of Clinical Pharmacology · 2015 · 150 citations

, , +16

Validation and application of Caco-2 assays for the<b><i>in vitro</i></b>evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions

Robert Elsby, Dominic Surry, Veronica Smith et al. · Xenobiotica · 2008 · 141 citations

, , +17

Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States

Bruce K. Birmingham, Sarah R. Bujac, Robert Elsby et al. · European Journal of Clinical Pharmacology · 2015 · 140 citations

, , +16

1–5 of 22